Non-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogenetics

Ibuprofen which is also known as : Advil, Advil Childrens, Advil Junior Strength, Advil Liquigel, Advil Migraine, Advil Pediatric, Childrens Ibuprofen Berry, Genpril, IBU, Midol IB, Midol Maximum Strength Cramp Formula, Dolgesic, Motrin Childrens, Motrin IB, Motrin Infant Drops, Motrin Junior Strength, Motrin Migraine Pain, Nuprin, Migraine Liqui-gels, Ibu-Tab 200, Cap-Profen, Tab-Profen, Profen, Ibuprohm, Children’s Elixsure, IB Pro, Vicoprofen, Combunox, A-G Profen, Actiprofen, Addaprin, Advil Infants Concentrated Drops, Caldolor, Haltran, Q-Profen, Ibifon 600, Ibren, Menadol, Midol Cramps & Bodyaches, Rufen, Saleto-200, Samson, Ultraprin, Uni-Pro, Wal-Profen.

Register for alerts
If you have registered for alerts, you should use your registered email address as your username

  • Citation tools Download this article to citation manager Arfè Andrea , Scotti Lorenza , Varas-Lorenzo Cristina , Nicotra Federica , Zambon Antonella , Kollhorst Bianca et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study BMJ 2016; 354 :i4857
    • BibTeX (win & mac) Download
    • EndNote (tagged) Download
    • EndNote 8 (xml) Download
    • RefWorks Tagged (win & mac) Download
    • RIS (win only) Download
    • Medlars Download
    Help If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

    Non-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogenetics

    non-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogenetics

    Media:

    non-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogeneticsnon-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogeneticsnon-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogeneticsnon-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogeneticsnon-steroidal anti-inflammatory drugs for cancer prevention promise perils and pharmacogenetics